logo
Billionaire Grant Cardone Warns ‘Simply Working Hard and Saving is No Longer a Successful Strategy' to Getting Rich

Billionaire Grant Cardone Warns ‘Simply Working Hard and Saving is No Longer a Successful Strategy' to Getting Rich

Yahoo13 hours ago
Grant Cardone, a self-made real estate mogul and entrepreneur, asserts that the path to financial success begins not with numbers or budgets, but with mindset. He argues that many Americans work diligently, purchase homes, and consistently save, yet still fall short of achieving financial independence.
According to Cardone, the key distinction between the merely hardworking and the truly wealthy is not just relentless effort, but the presence of a comprehensive plan specifically designed to accumulate wealth. In a recent post on X, Cardone said, 'The first thing to fix about finance is your mind. If you want proof of this just look at most of America. They work hard, buy a house, and save more than they spend yet still never attain financial freedom.' Cardone continued, 'The second thing to do is to have a wealth plan designed to create wealth. 83% of all wealthy people had a plan in place in order to create their wealth.'
More News from Barchart
Warren Buffett Warns Inflation Turns Business Into 'The Upside-Down World of Alice in Wonderland' But Weeds Out 'Bad Businesses'
Why GOOGL Stock May Be the Market's Next Big Winner
Alphabet Posts Lower Free Cash Flow and FCF Margins - Is GOOGL Stock Overvalued?
Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!
Cardone emphasizes that a significant majority of wealthy individuals — over 80% — did not leave financial success to chance but followed a precise plan during their journey. This insight is supported by studies indicating that about 83-84% of high-net-worth individuals intentionally chart long-term financial plans, contrasted with just over half of the general population. This highlights the important role structured planning plays in differentiating wealth accumulation from simple financial stability.
'Simply working hard and saving is no longer a successful strategy as interest rates on savings will not keep up with the destruction of currency and taxes. Those who attain real wealth have a plan for their freedom whereby they earn to invest and then later borrow against appreciated assets to reduce taxes,' said Cardone, emphasizing the importance of investing in productive assets and reducing ones tax liability. Cardone continued, 'They aren't saving for the sake of saving, they are saving to create asset wealth and then one day passive streams of income that outpace inflation.'
Why Cardone's Perspective Carries Weight
Grant Cardone brings considerable authority to the topic. With a background spanning from modest beginnings to founding multi-million dollar enterprises, Cardone's rise embodies the principles he espouses. He operates Cardone Capital, manages a multi-billion-dollar property portfolio, and is an internationally recognized sales trainer and best-selling author. His teachings have appeared in major financial media outlets and corporate boardrooms, shaping the strategies of both Fortune 500 firms and everyday investors.
Central to Cardone's approach is the belief that financial growth requires mindset shifts away from conventional approaches. He is known for promoting aggressive growth, calculated risk-taking, and the use of leverage to build long-term wealth. His critique of simple saving is rooted in economic realities: with inflation outpacing interest rates on traditional savings accounts, money held idle risks losing value over time. This view resonates amid modern market conditions, where rising living costs and shifting interest rates frequently erode purchasing power.
The Wealth Plan in Practice
Cardone notes that true wealth is built not merely by saving more than spending, but by converting earnings into investments and building diverse asset bases — especially those offering passive income. He advocates for a systematic approach where savings serve as building blocks for acquiring appreciating assets, such as real estate or business equity. Rather than hoarding cash, he suggests that disciplined investments and strategically borrowing against growing assets can reduce tax liabilities and create income flows that keep pace with inflation.
This guidance aligns with prevailing financial advice for those seeking independence: develop passive income streams, invest intelligently, and adjust strategies based on economic shifts. For many Americans, Cardone's message may challenge ingrained habits, but it reflects a pragmatic response to evolving market realities.
Relevance in Today's Markets
Cardone's counsel addresses the perennial challenges faced by savers and investors: how to navigate inflation, wealth inequality, and the unpredictability of markets. As savings account interest rates often lag behind inflation, and the cost of living continues to climb, the call to focus on asset-building and strategic planning is particularly salient.
Ultimately, Cardone's approach centers on the belief that financial freedom is not accidental, but a result of conscious mindset shifts and disciplined, forward-looking planning — a principle that has defined both his career trajectory and his message to millions.
On the date of publication, Caleb Naysmith did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time8 minutes ago

  • Yahoo

Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here's what investors should know. Hologic met analysts' revenue expectations last quarter, reporting revenues of $1.01 billion, down 1.2% year on year. It was a slower quarter for the company, with a slight miss of analysts' full-year EPS guidance estimates and full-year revenue guidance meeting analysts' expectations. Is Hologic a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Hologic's revenue to be flat year on year at $1.01 billion, slowing from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.05 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hologic has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.9% on average. Looking at Hologic's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Hologic is up 2.8% during the same time and is heading into earnings with an average analyst price target of $69.93 (compared to the current share price of $66.99). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio

CONMED (CNMD) Q2 Earnings: What To Expect
CONMED (CNMD) Q2 Earnings: What To Expect

Yahoo

time8 minutes ago

  • Yahoo

CONMED (CNMD) Q2 Earnings: What To Expect

Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here's what to look for. CONMED beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $321.3 million, up 2.9% year on year. It was a very strong quarter for the company, with a solid beat of analysts' full-year EPS guidance estimates and an impressive beat of analysts' EPS estimates. Is CONMED a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting CONMED's revenue to grow 1.9% year on year to $338.3 million, slowing from the 4.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CONMED has missed Wall Street's revenue estimates three times over the last two years. Looking at CONMED's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. CONMED is down 4% during the same time and is heading into earnings with an average analyst price target of $66.60 (compared to the current share price of $50.02). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings
Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time8 minutes ago

  • Yahoo

Kraft Heinz (KHC) Reports Q2: Everything You Need To Know Ahead Of Earnings

Packaged foods company Kraft Heinz (NASDAQ:KHC) will be reporting results this Wednesday before market open. Here's what investors should know. Kraft Heinz met analysts' revenue expectations last quarter, reporting revenues of $6.00 billion, down 6.4% year on year. It was a mixed quarter for the company, with a narrow beat of analysts' EBITDA estimates but full-year EPS guidance missing analysts' expectations. Is Kraft Heinz a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Kraft Heinz's revenue to decline 3.1% year on year to $6.27 billion, in line with the 3.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.64 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 4 downward revisions over the last 30 days (we track 10 analysts). Looking at Kraft Heinz's peers in the shelf-stable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Lamb Weston delivered year-on-year revenue growth of 4%, beating analysts' expectations by 5.7%, and McCormick reported flat revenue, in line with consensus estimates. Lamb Weston traded up 19.3% following the results while McCormick was also up 3.6%. Read our full analysis of Lamb Weston's results here and McCormick's results here. There has been positive sentiment among investors in the shelf-stable food segment, with share prices up 3.8% on average over the last month. Kraft Heinz is up 9.3% during the same time and is heading into earnings with an average analyst price target of $30.18 (compared to the current share price of $28.22). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store